文献速递儿童青少年精神

加速间歇性θ爆发刺激靶向个体化额顶控制网络改善孤独症谱系障碍核心症状:双盲随机对照试验

Accelerated intermittent theta burst stimulation targeting personalized fronto-parietal control network improves core symptoms of autism spectrum disorder: a double-blind, randomized controlled trial.
PubMed 文献 · Mol Psychiatry · 2026-04-15

这项双盲假对照随机临床试验评估了靶向个体化额顶网络(FPN)的加速间歇性θ爆发刺激(iTBS)在6-30岁孤独症谱系障碍(ASD)患者中的疗效。主动iTBS组应答率显著高于假刺激组(55% vs. 29%),症状改善更明显(Cohen's d = -0.53),仅5%出现轻度局部疼痛。在深度孤独症亚组中,主动组语言改善并伴随核心症状缓解。

要点

  • 加速FPN靶向iTBS可显著提高ASD核心症状应答率(55% vs. 29%)。
  • 主动iTBS症状改善优于假刺激(Cohen's d = -0.53),安全性良好。
  • 深度孤独症亚组中主动iTBS伴随语言改善和核心症状缓解。

核心结论

  • prolonged加速FPN靶向iTBS对严重ASD是安全有效的干预,提供有前景的治疗途径。

研究设计与样本

  • 双盲假对照随机临床试验,6-30岁ASD患者按2:1随机分配至主动或假iTBS,每日三次、每次1800脉冲,共12周(324k脉冲),联合行为训练。
  • 筛查132人,随机67人(平均年龄10.04±4.22岁;88.1%男性;所有患者均有认知/适应延迟),59人完成研究。

主要发现

  • 主动iTBS组应答率显著高于假刺激组(55% vs. 29%)。
  • 主动iTBS症状改善优于假刺激(Cohen's d = -0.53)。
  • 仅5%的iTBS组出现轻度局部疼痛。
  • 深度孤独症亚组中,主动组语言改善并伴随核心症状缓解。

关键数值与推荐

  • 主要结局为应答率,定义为第12周ADOS-2 SA评分降低≥1分。
  • 主动iTBS应答率55%,假刺激29%。
  • 症状改善效应量Cohen's d = -0.53。

临床怎么用

  • 对于6-30岁伴有认知/适应延迟的严重ASD患者,可考虑个体化FPN靶向加速iTBS联合行为训练。
  • 治疗需关注轻度局部疼痛(发生率5%)。

局限性

  • 样本量较小(随机67人,完成59人),可能限制统计效能和亚组分析可靠性。
  • 所有患者均有认知/适应延迟,结果推广至无延迟ASD人群需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Autism Spectrum Disorder (ASD) presents a substantial global challenge, yet no pharmacological treatments effectively target its core symptoms, especially in individuals with severe cognitive or adaptive impairments. This double-blind, sham-controlled, randomized clinical trial assessed accelerated intermittent theta burst stimulation (iTBS) targeting the personalized fronto-parietal network (FPN) in ASD. Participants (6-30 years) were randomized in a 2:1 ratio to active or sham iTBS (three daily sessions, 1800 pulses/session) over 12 weeks (324k pulses) alongside behavioral training. The primary outcome was defined as the response rate, charaterized by a ≥ 1-point reduction in ADOS-2 SA at week 12. Of 132 individuals screened, 67 were randomized (mean age 10.04 ± 4.22 years; 88.1% male; all with cognitive/adaptive delays), with 59 completing the study. Active iTBS resulted in a significantly higher response rate (55% vs. 29%) and higher symptom improvement than sham (cohen's d = -0.53), with mild local pain in only 5% of iTBS group. In the profound autism subgroup, the active group exhibited language improvement alongside amelioration of core symptoms. These findings suggest that prolonged, accelerated FPN-targeted iTBS is a safe and efficacious intervention for severe ASD, offering a promising therapeutic approach.Registration ClinicalTrials.gov Identifier: NCT05890846.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Liu Q, Zhang J, Duan X, et al. Accelerated intermittent theta burst stimulation targeting personalized fronto-parietal control network improves core symptoms of autism spectrum disorder: a double-blind, randomized controlled trial. Mol Psychiatry. 2026. PMID: 41986743. doi:10.1038/s41380-026-03596-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。